Cooperativity of the oncoprotein SKI and the mutated receptor tyrosine kinase FLT3ITD in acute myeloid leukemia patients with normal karyotype

被引：0
|
作者：
Frech, M. [1 ,2 ]
Mernberger, M. [3 ]
Nist, A. [4 ]
Sengelmann, M. [1 ,2 ]
Alkan, A. [1 ,2 ]
Kellermann, T. [1 ,2 ]
Steding, H. [1 ,2 ]
Stiewe, T. [3 ,4 ]
Neubauer, A. [1 ,2 ]
机构：
[1] Philipps Univ Marburg, Clin Hematol Oncol, Immunol, Marburg, Germany
[2] Philipps Univ Marburg, Ctr Tumor Biol & Immunol, Marburg, Germany
[3] Philipps Univ Marburg, Inst Mol Oncol, Marburg, Germany
[4] Philipps Univ Marburg, Genom Core Facil, Marburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V1077
引用
收藏
页码：310 / 310
页数：1
相关论文
共 50 条
  • [1] Glutaminolysis is a metabolic dependency in FLT3ITD acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition
    Gallipoli, Paolo
    Giotopoulos, George
    Tzelepis, Konstantinos
    Costa, Ana S. H.
    Vohra, Shabana
    Medina-Perez, Paula
    Basheer, Faisal
    Marando, Ludovica
    Di Lisio, Lorena
    Dias, Joao M. L.
    Yun, Haiyang
    Sasca, Daniel
    Horton, Sarah J.
    Vassiliou, George
    Frezza, Christian
    Huntly, Brian J. P.
    BLOOD, 2018, 131 (15) : 1639 - 1653
  • [2] FUNCTIONAL INTERACTION BETWEEN FLT3ITD AND TELOMERASE IN ACUTE MYELOID LEUKEMIA (AML)
    Xu, D.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2013, 40 : 11 - 12
  • [3] Evaluation of tyrosine kinase inhibitor treatment in patients with FLT3-ITD positive acute myeloid leukemia
    Fleischmann, M.
    Schrenk, K. G.
    Schnetzke, U.
    Hilgendorf, I
    Hochhaus, A.
    Scholl, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 50 - 51
  • [4] Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutation
    Jiang, Allan
    Jiang, Hua
    Brandwein, Joseph
    Kamel-Reid, Suzanne
    Chang, Hong
    LEUKEMIA RESEARCH, 2011, 35 (04) : 492 - 498
  • [5] Maintenance therapy for FLT3-ITD-mutated acute myeloid leukemia
    Burchert, Andreas
    HAEMATOLOGICA, 2021, 106 (03) : 664 - 670
  • [6] The presence of FLT3/ITD mutations is an independent prognostic factor in acute myeloid leukemia patients with normal karyotype.
    Kim, YK
    Lee, JJ
    Lee, YR
    Lee, IK
    Kim, HN
    Kim, NY
    Park, KS
    Yang, DH
    Park, MR
    Kim, HJ
    BLOOD, 2004, 104 (11) : 822A - 822A
  • [7] Prognostic Impact of Immunophenotyping for Normal Karyotype Acute Myeloid Leukemia in the Absence of FLT3-ITD Mutation
    Jiang, A.
    Jiang, H.
    Xu, W.
    Brandwein, J.
    Kamel-Reid, S.
    Chang, H.
    MODERN PATHOLOGY, 2010, 23 : 305A - 305A
  • [8] Prognostic Impact of Immunophenotyping for Normal Karyotype Acute Myeloid Leukemia in the Absence of FLT3-ITD Mutation
    Jiang, A.
    Jiang, H.
    Xu, W.
    Brandwein, J.
    Kamel-Reid, S.
    Chang, H.
    LABORATORY INVESTIGATION, 2010, 90 : 305A - 305A
  • [9] The FLT3 tyrosine kinase receptor ITD mutation controls its expression and drug resistance in acute myeloid leukemia
    Alqahtani, Taha
    MacEwan, David
    CANCER RESEARCH, 2024, 84 (06)
  • [10] The potential of triplet combination therapies for patients with FLT3-ITD -mutated acute myeloid leukemia
    Bruzzese, Antonella
    Vigna, Ernesto
    Martino, Enrica Antonia
    Labanca, Caterina
    Mendicino, Francesco
    Lucia, Eugenio
    Olivito, Virginia
    Stanzione, Gaia
    Zimbo, Annamaria
    Lugli, Elisabetta
    Neri, Antonino
    Morabito, Fortunato
    Gentile, Massimo
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (06) : 241 - 253
12345